Search Results - "Cicero, Arrigo F.G"

Refine Results
  1. 1

    Clinical Effects of Xanthine Oxidase Inhibitors in Hyperuricemic Patients by Cicero, Arrigo F.G., Fogacci, Federica, Cincione, Raffaele Ivan, Tocci, Giuliano, Borghi, Claudio

    Published in Medical principles and practice (01-04-2021)
    “…This review aims to critically present the available clinical evidence supporting the treatment of chronic hyperuricemia with xanthine oxidase inhibitors. For…”
    Get full text
    Journal Article
  2. 2

    Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders by Caliceti, Cristiana, Franco, Placido, Spinozzi, Silvia, Roda, Aldo, Cicero, Arrigo F G

    Published in Current medicinal chemistry (01-04-2016)
    “…Berberine is a quaternary ammonium salt from the protoberberine group of isoquinoline alkaloids found in such plants as gender Berberis. Berberine is…”
    Get more information
    Journal Article
  3. 3

    Regulatory effects of berberine on microRNome in Cancer and other conditions by Ayati, Seyed Hasan, Fazeli, Badrieh, Momtazi-borojeni, Amir Abbas, Cicero, Arrigo F.G, Pirro, Matteo, Sahebkar, Amirhossein

    Published in Critical reviews in oncology/hematology (01-08-2017)
    “…Abstract Berberine (BBR) is an isoquinoline alkaloid found in different plant families such as Berberidaceae, Ranunculaceae, and Papaveraceae. BBR is…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects by Cicero, Arrigo F.G, Rosticci, Martina, Fogacci, Federica, Grandi, Elisa, D'Addato, Sergio, Borghi, Claudio

    Published in European journal of internal medicine (01-01-2017)
    “…Abstract Introduction Serum uric acid (SUA) has been associated to incident hypertension and increased risk of cardiovascular diseases. Materials and methods…”
    Get full text
    Journal Article
  7. 7

    Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment by Gitto, Stefano, Cicero, Arrigo F.G, Loggi, Elisabetta, Giovannini, Marina, Conti, Fabio, Grandini, Elena, Guarneri, Valeria, Scuteri, Alessandra, Vitale, Giovanni, Cursaro, Carmela, Borghi, Claudio, Andreone, Pietro

    Published in Annals of hepatology (2018)
    “…AbstractIntroduction. Host lipid metabolism influences viral replication and lifecycle of hepatitis C virus. Our aim was to evaluate changes in glucose and…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Serum uric acid and other short-term predictors of electrocardiographic alterations in the Brisighella Heart Study cohort by Cicero, Arrigo F.G, Rosticci, Martina, Tocci, Giuliano, Bacchelli, Stefano, Urso, Riccado, D'Addato, Sergio, Borghi, Claudio

    Published in European journal of internal medicine (01-05-2015)
    “…Abstract Introduction Recent studies show that serum uric acid (SUA) is a predictor of atrial fibrillation, while its association with other kinds of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Role of phytochemicals in the management of metabolic syndrome by Cicero, Arrigo F.G., Colletti, Alessandro

    Published in Phytomedicine (Stuttgart) (15-10-2016)
    “…The World Health Organization (WHO) for some years has been focusing on what is now commonly referred to as an "epidemic of obesity and diabetes"…”
    Get full text
    Journal Article
  13. 13

    Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients by Derosa, Giuseppe, Maffioli, Pamela, Ferrari, Ilaria, D’Angelo, Angela, Fogari, Elena, Palumbo, Ilaria, Randazzo, Sabrina, Cicero, Arrigo F.G.

    Published in ENDOCRINE JOURNAL (2010)
    “…Our study wants to evaluate the effects of one year treatment with orlistat plus L-carnitine compared to orlistat alone on body weight, glycemic and lipid…”
    Get full text
    Journal Article
  14. 14

    Variations in Inflammatory Biomarkers Following the Addition of Sitagliptin in Patients with Type 2 Diabetes not Controlled with Metformin by Derosa, Giuseppe, Carbone, Anna, D'Angelo, Angela, Querci, Fabrizio, Fogari, Elena, Cicero, Arrigo F.G., Maffioli, Pamela

    Published in Internal Medicine (01-01-2013)
    “…Objective The effects of dipeptidyl peptidase-4 (DPP-4) inhibition on adipose tissue inflammation remain obscure. The aim of this study was to evaluate the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study by Cicero, Arrigo F.G, Salvi, Paolo, D’Addato, Sergio, Rosticci, Martina, Borghi, Claudio

    Published in Journal of hypertension (01-01-2014)
    “…OBJECTIVE:Serum uric acid (SUA) levels correlate with many recognized cardiovascular risk factors, including age, male sex, hypertension, diabetes mellitus,…”
    Get full text
    Journal Article
  17. 17

    Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data by Cicero, Arrigo F.G., Colletti, Alessandro

    Published in Phytomedicine (Stuttgart) (15-10-2016)
    “…Cardiovascular diseases are the primary cause of death and the leading cause of disability in industrialized countries. Dyslipidemia is a major independent and…”
    Get full text
    Journal Article
  18. 18

    Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan by Kuwabara, Masanari, Borghi, Claudio, Cicero, Arrigo F.G., Hisatome, Ichiro, Niwa, Koichiro, Ohno, Minoru, Johnson, Richard J., Lanaspa, Miguel A.

    Published in International journal of cardiology (15-06-2018)
    “…High serum uric acid (SUA) is associated with the dyslipidemia, but whether hyperuricemia predicts an increase in serum low-density lipoprotein (LDL)…”
    Get full text
    Journal Article
  19. 19

    Effect of extended-release niacin on plasma Lipoprotein(a) levels: a systematic review and meta-analysis of randomized placebo-controlled trials by Sahebkar, Amirhosssein, Reiner, Željko, Simental-Mendía, Luis E, Ferretti, Gianna, Cicero, Arrigo F.G

    Published in Metabolism, clinical and experimental (01-11-2016)
    “…Abstract Aim Lipoprotein(a) (Lp(a)) is a proatherogenic and prothrombotic lipoprotein. Our aim was to quantify the extended-release nicotinic acid Lp(a)…”
    Get full text
    Journal Article
  20. 20